188 related articles for article (PubMed ID: 12384431)
1. Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicity.
Caragine TA; Imai M; Frey AB; Tomlinson S
Blood; 2002 Nov; 100(9):3304-10. PubMed ID: 12384431
[TBL] [Abstract][Full Text] [Related]
2. A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer.
Caragine TA; Okada N; Frey AB; Tomlinson S
Cancer Res; 2002 Feb; 62(4):1110-5. PubMed ID: 11861390
[TBL] [Abstract][Full Text] [Related]
3. Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells.
Quigg RJ; Morgan BP; Holers VM; Adler S; Sneed AE; Lo CF
Kidney Int; 1995 Aug; 48(2):412-21. PubMed ID: 7564108
[TBL] [Abstract][Full Text] [Related]
4. Rat T cells express neither CD55 nor CD59 and are dependent on Crry for protection from homologous complement.
Hanna S; Spiller O; Linton SM; Mead RJ; Morgan B
Eur J Immunol; 2002 Feb; 32(2):502-9. PubMed ID: 11828367
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Crry protects mesangial cells from complement-mediated injury.
Nangaku M; Quigg RJ; Shankland SJ; Okada N; Johnson RJ; Couser WG
J Am Soc Nephrol; 1997 Feb; 8(2):223-33. PubMed ID: 9048341
[TBL] [Abstract][Full Text] [Related]
6. CD59 homologue regulates complement-dependent cytolysis of rat Schwann cells.
Sawant-Mane S; Piddlesden SJ; Morgan BP; Holers VM; Koski CL
J Neuroimmunol; 1996 Sep; 69(1-2):63-71. PubMed ID: 8823377
[TBL] [Abstract][Full Text] [Related]
7. Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis.
Quigg RJ; Holers VM; Morgan BP; Sneed AE
J Immunol; 1995 Apr; 154(7):3437-43. PubMed ID: 7534798
[TBL] [Abstract][Full Text] [Related]
8. Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins.
Sohn JH; Kaplan HJ; Suk HJ; Bora PS; Bora NS
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3492-502. PubMed ID: 11006244
[TBL] [Abstract][Full Text] [Related]
9. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.
Miwa T; Zhou L; Hilliard B; Molina H; Song WC
Blood; 2002 May; 99(10):3707-16. PubMed ID: 11986227
[TBL] [Abstract][Full Text] [Related]
10. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
Molina H; Miwa T; Zhou L; Hilliard B; Mastellos D; Maldonado MA; Lambris JD; Song WC
Blood; 2002 Dec; 100(13):4544-9. PubMed ID: 12393518
[TBL] [Abstract][Full Text] [Related]
11. Suppression of complement regulatory proteins (CRPs) exacerbates experimental autoimmune anterior uveitis (EAAU).
Jha P; Sohn JH; Xu Q; Wang Y; Kaplan HJ; Bora PS; Bora NS
J Immunol; 2006 Jun; 176(12):7221-31. PubMed ID: 16751365
[TBL] [Abstract][Full Text] [Related]
12. Development of adenovirus vectors encoding rat complement regulators for use in therapy in rodent models of inflammatory diseases.
McGrath Y; Wilkinson GW; Spiller OB; Morgan BP
J Immunol; 1999 Dec; 163(12):6834-40. PubMed ID: 10586084
[TBL] [Abstract][Full Text] [Related]
13. Specific collaboration between rat membrane complement regulators Crry and CD59 protects peritoneum from damage by autologous complement activation.
Mizuno T; Mizuno M; Morgan BP; Noda Y; Yamada K; Okada N; Yuzawa Y; Matsuo S; Ito Y
Nephrol Dial Transplant; 2011 Jun; 26(6):1821-30. PubMed ID: 21098015
[TBL] [Abstract][Full Text] [Related]
14. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
15. Requirement of leukocytic cell adhesion molecules (CD11a-c/CD18) in the enhanced NK lysis of iC3b-opsonized targets.
Ramos OF; Patarroyo M; Yefenof E; Klein E
J Immunol; 1989 Jun; 142(11):4100-4. PubMed ID: 2565929
[TBL] [Abstract][Full Text] [Related]
16. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF.
Li B; Sallee C; Dehoff M; Foley S; Molina H; Holers VM
J Immunol; 1993 Oct; 151(8):4295-305. PubMed ID: 7691944
[TBL] [Abstract][Full Text] [Related]
17. Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria.
Hori Y; Yamada K; Hanafusa N; Okuda T; Okada N; Miyata T; Couser WG; Kurokawa K; Fujita T; Nangaku M
Kidney Int; 1999 Dec; 56(6):2096-106. PubMed ID: 10594785
[TBL] [Abstract][Full Text] [Related]
18. CD59 protects rat kidney from complement mediated injury in collaboration with crry.
Watanabe M; Morita Y; Mizuno M; Nishikawa K; Yuzawa Y; Hotta N; Morgan BP; Okada N; Okada H; Matsuo S
Kidney Int; 2000 Oct; 58(4):1569-79. PubMed ID: 11012891
[TBL] [Abstract][Full Text] [Related]
19. CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma.
Chen S; Caragine T; Cheung NK; Tomlinson S
Cancer Res; 2000 Jun; 60(11):3013-8. PubMed ID: 10850450
[TBL] [Abstract][Full Text] [Related]
20. Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells.
Finberg RW; White W; Nicholson-Weller A
J Immunol; 1992 Sep; 149(6):2055-60. PubMed ID: 1381394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
